【杨人上：深耕融合创新，共筑健康生态】在健康中国战略深入推进的当下，大健康产业正迎来前所未 有的发展机遇，同时也面临着产业变革与模式创新的时代命题。近日，在#第十二届中国商业创新大会# 健康中国高峰论坛落幕之际，郑州商业企业家联合会会长、优德体育YFU董事长杨人上接受中国商报记 者专访，围绕大健康产业的融合趋势、商业模式创新、区域生态构建等核心话题分享了他的洞察与实 践。作为深耕大健康领域多年的从业者，杨人上见证了产业从单一医疗服务向全生命周期健康管理的深 刻变革。谈及当前大健康产业的发展态势，他直言"融合"已成为不可逆转的潮流。（中国商报记者 王 怡菲）详情戳： #这样喝咖啡反而促癌##顽固性打嗝可能是胃癌前兆# 转自：中国商报 （来源：中国商报） ...

Group 1 - The core product is a man-made blood vessel designed for abdominal aortic replacement, repair, or bypass surgery, developed by Yuyue Group's subsidiary Shandong Xinyue Health Technology Co., Ltd. [1] - The artificial blood vessel is made from specialized medical polyester material and features a proprietary biological coating that promotes rapid endothelialization and minimizes rejection reactions [1][2] - The product has been successfully tested in over 130 surgeries, with positive clinical feedback, and is expected to enter the industrialization phase soon, potentially reducing costs by over 50% [2] Group 2 - Yuyue Group's strategy in the health industry includes a comprehensive health ecosystem, integrating health product development and health management services [2][3] - The "Wan Doctor" initiative combines various health resources, including screening for health risks, expert consultations, and nationwide referral services, supported by a team of specialists and digital health monitoring [3] - The integration of traditional textile technology with medical health is driving innovation in both sectors, with medical needs pushing textile technology advancements and textile innovations providing new momentum for the health industry [3]

Group 1 - The health insurance industry is undergoing significant transformation driven by factors such as policy direction, market demand, product innovation, and service upgrades, with a shift from traditional disease insurance to products focusing on medical expense coverage [1][2][3] - The launch of "Health Appointment Light Version" by Taikang Life offers a 10-year guaranteed renewal, better rate leverage, coverage for special medical needs, and compensation for outpatient drugs and devices, providing consumers with a high-cost performance health insurance option [1][3][4] - The demand for high-quality medical services is increasing, particularly among high-net-worth individuals seeking premium medical care and overseas treatments, while middle-income groups focus on cost-effectiveness, leading to a stratified and cyclical demand in the health insurance market [2][3][6] Group 2 - The aging population in China is projected to reach 310 million by the end of 2024, with 22% of the population aged 60 and above, resulting in a significant shift in health demand towards high-end medical and rehabilitation care [6][7] - There is a notable imbalance in the supply and demand for high-end medical services, particularly in certain regions, while the demand for chronic disease rehabilitation is rapidly increasing, highlighting the urgent need for improved rehabilitation care services [6][7] - Taikang Life's "Light Version" integrates health management and services, offering comprehensive health management services including health consultations and medical services, while also breaking the limitation of rehabilitation institutions not being able to claim insurance [7][8][9] Group 3 - The global market for overseas medical services exceeds $300 billion and is growing at over 10% annually, with some Chinese patients opting for overseas treatment due to insufficient domestic high-end medical supply [3][4] - The health insurance sector is encouraged to evolve from merely being a compensation tool to providing comprehensive health management services, enhancing customer experience and promoting preventive care [8][9] - The integration of health insurance with health management is seen as crucial for optimizing health insurance payouts and improving overall health outcomes for clients, shifting the focus from disease treatment to health maintenance [9]